Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05175417
Other study ID # 21-6105
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 29, 2022
Est. completion date December 31, 2025

Study information

Verified date May 2024
Source University Health Network, Toronto
Contact Tasnuva T Hoque, BSc
Phone 4166035800
Email tasnuva.hoque@uhnresearch.ca
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Functional neurosurgery is dedicated to modulating aberrant neural circuits associated with a wide range of neurological conditions. Recently, technological advances in MRI have permitted marked improvements in the direct visualization of neural targets, which is necessary for the accurate targeting in functional neurosurgery procedures. This research study focuses on imaging patient brains before their scheduled procedures by using a 3 tesla (T) MRI to provide higher resolution and quality brain images. The reason for this study is to assess the image quality using different MRI sequences or settings to improve the image resolution of the most common functional neurosurgery targets (e.g., subthalamic nucleus, globus pallidus, and thalamus) and compare the image quality of the brains in patients with healthy controls. Performing a preoperative MRI is standard-of-care for patients indicated for deep brain stimulation (DBS), gamma knife radiosurgery (GKRS), radiofrequency ablation (RFA), magnetic resonance-guided focused ultrasound (MRgFUS). MRI sequence parameters shown to improve the image quality of different neural structures in a recent literature review (Boutet et al. 2021) will be reproduced on the 3T MRI at Toronto Western Hospital.


Description:

This is an exploratory prospective experimental study that will assess the ability of different MRI sequences to visualize common functional neurosurgical targets. Some neural structures (i.e., STN) are sometimes not visualized as well, particularly in older patients, when compared to healthy controls. The findings from this study should help in identifying the advanced sequences for direct visualization of these targets, that could then be used for improved preoperative planning of functional neurosurgical procedures. Several advanced MRI sequences will be conducted when imaging patients or healthy participant. All advanced sequences have previously been published in the literature as viable, safe preoperative planning sequences for functional neurosurgical treatments at other centres. All MRI scans in this study will be acquired at the Toronto Western Hospital (TWH). For example, structural scans using sequences that can null or not receive signals from fluids in the brain and reduce geometric distortion (i.e., fluid attenuated inversion recovery (FLAIR)), null white matter signals (i.e., fast gray matter acquisition T1 inversion recovery (FGATIR)), and enhance the visualization of iron concentrated neural structures (i.e., quantitative susceptibility mapping (QSM)) will be performed. These advanced sequences will be compared to conventional structural MRI sequences (i.e., T1-weighted (T1W) or T2-weighted (T2W)) that are typically used for anatomical purposes and direct visualization of neural structures. Ultimately, results from this study should enhance quality of care, clinical benefits, and data quality.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 31, 2025
Est. primary completion date August 29, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Age between 18 and 85 years of age. - Preparing to undergo a functional neurosurgical intervention (e.g., DBS, RFA, GKR or MRgFUS) at TWH (not applicable for healthy volunteers). - Participants must be able to understand the purpose of this research and must sign the informed consent form. - Participants must understand that the role of this research is to enhance our understanding of brain functioning and that he/she will not directly or indirectly benefit from the study. Exclusion Criteria: - Contraindication for an MRI (e.g., implanted cardiac device, metal in eyes, aneurysm clip, etc.). - Participants who have serious cognitive or psychological impairments and cannot give informed consent. - Participants who are unable to communicate effectively or efficiently (e.g., patients suffering from speech deficits (dysarthria, aphasia) or are non-English speaking).

Study Design


Related Conditions & MeSH terms


Intervention

Other:
MRI
3 tesla (T) MRI to provide higher resolution and quality brain images.

Locations

Country Name City State
Canada Toronto Western Hospital Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
University Health Network, Toronto

Country where clinical trial is conducted

Canada, 

References & Publications (1)

Boutet A, Loh A, Chow CT, Taha A, Elias GJB, Neudorfer C, Germann J, Paff M, Zrinzo L, Fasano A, Kalia SK, Steele CJ, Mikulis D, Kucharczyk W, Lozano AM. A literature review of magnetic resonance imaging sequence advancements in visualizing functional neurosurgery targets. J Neurosurg. 2021 Mar 26;135(5):1445-1458. doi: 10.3171/2020.8.JNS201125. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Quantitative image quality metrics Two quantitative image quality metrics commonly used are contrast-to-noise ratio (CNR) and signal-to-noise ratio (SNR). CNR (i.e., the ratio of the contrast between the signal in a given region and the background) is a measure of the contrast between the tissue of interest and the neighboring tissue. Similarly, SNR is a measure of the average image signal in a given region to the neighboring tissue or the noise around the region of interest. = 1 week before surgery
Primary Qualitative image quality metrics Qualitative image quality metrics will assess the image quality and clinical acceptability of each scan in a randomized order. Each scan will be scored using a 5-point Likert scale by expert raters. An overall average score will be calculated for each MRI sequence. = 1 week before surgery
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05586750 - Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy Phase 4
Completed NCT04050800 - Carbon-11 Butanol: Whole Body Radiochemical and Radiation Safety Early Phase 1
Recruiting NCT04863859 - Persons With Dementia and Their Extended Family Caregivers
Recruiting NCT05655650 - Identifying Biomarkers in Alzheimer's Disease
Completed NCT04937127 - Efficiency of E-learning and Role-playing for the Training of Nursing Home Caregivers in the Support of Agitation in Neurodegenerative Diseases
Enrolling by invitation NCT03197363 - BiaƂystok PLUS - Polish Longitudinal University Study
Enrolling by invitation NCT03322306 - Establishment of Genetic Basis for Neurological Disease by Genetic Screening
Completed NCT03439163 - Large Sample PD Patients and Healthy Controls N/A
Withdrawn NCT05921929 - First-In-Human (FIH), Single Ascending Dose (SAD) Study of FluoroEthylNorMemantine (FENM) Phase 1
Recruiting NCT05209698 - Self-Management Behaviors of Arabs and Jews With Parkinson's Disease and Their Associations With Health Outcomes
Completed NCT04362228 - The Effects of Whole-body Exercise to Improve Swallowing Function in Older Adults With Dementia N/A
Enrolling by invitation NCT05008094 - The Epidemiology of Parkinson's Disease in Croatia and the Influence of Genetic Factors and Microbiota on the Progression and Treatment Outcomes of the Disease (GiOPARK)
Completed NCT03279991 - Neuromed- Integrated Health Life Platform and Biobank
Active, not recruiting NCT04228653 - Long-Term Follow-up Safety After DDS Implantation With/Without CDNF Infusions Phase 1/Phase 2
Recruiting NCT05328492 - Volume Mode Non-invasive Ventilation in Amyotrophic Lateral Sclerosis N/A
Not yet recruiting NCT06151600 - A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J
Recruiting NCT04880356 - Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.
Active, not recruiting NCT03609125 - Cord Blood Serum in the Treatment of Neuro-Degenerative Ophthalmic Diseases. 1-Glaucoma N/A
Recruiting NCT03153670 - 3T MRI in Patients With Deep Brain Stimulation (DBS) N/A
Completed NCT03775538 - Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study Phase 1/Phase 2